• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/68 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member

Patent holdings for IPC class C07D 211/68

Total number of patents in this class: 67

10-year publication summary

0
2
0
2
0
0
2
3
1
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Boehringer Ingelheim International GmbH
4650
5
Alkahest, Inc.
96
3
Ardelyx, Inc.
113
3
Cytokinetics, Inc.
277
3
Zevra Therapeutics, Inc.
99
3
Bristol-myers Squibb Company
4898
2
Janssen Pharmaceutica N.V.
3392
2
Bioinformatics & Molecular Design Research Center
9
2
Dekk-Tec, Inc.
8
2
Epizyme, Inc.
370
2
Medigenes Co., Ltd.
9
2
Nerviano Medical Sciences S.r.l.
256
2
Neurocrine Biosciences, Inc.
419
2
Richter Gedeon Nyrt.
1634
2
Prilenia Neurotherapeutics Ltd.
88
2
Novartis AG
10849
1
Hoffmann-La Roche Inc.
3418
1
LG Chem, Ltd.
17632
1
Bayer Cropscience AG
2035
1
University of Florida Research Foundation, Inc.
4020
1
Other owners 25